The Indian biotech industry has stupendously grown during the past few years on the back of a large pool of scientific talent, world-class information technology industry, and vibrant pharmaceutical sector. Moreover, our research has found that, among the segments, the biopharma segment constitutes a major part of the total biotech market. The biopharmaceutical segment will be further benefited from the fact that India has the capabilities and requisite talent to become a major supplier of biogeneric to the developed world in coming years. As per our research report “Booming Biotech Market in India”, the biopharmaceutical segment is projected to grow at a CAGR of around 12% during FY 2011 - FY 2013.